Ceftolozane

头孢洛生

Report date: 2025/12/04 20:00:08
NME

Base Information

Drug NameCeftolozane
Drug Alias Name头孢洛扎Ceftolozane SulfateceftolozanoceftolozanumCeftolozane Sulfate WS 0420 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPenicillin-binding protein 3 inhibitorsPenicillin-binding protein 1b inhibitors
TargetsPenicillin-binding protein 1bPenicillin-binding protein 3
Therapy Area/IndicationsPyelonephritisUrinary Tract InfectionsIntraabdominal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineSlovakia +[25] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of QueenslandCubist Pharmaceuticals LlcMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsPyelonephritisUrinary Tract InfectionsIntraabdominal Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG